Pierluigi Zinzani

167PUBLICATIONS
707CO-AUTHORS
AllergyPredictive and prognostic markersHaematological tumoursImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (167)

|Aug 11, 2026
Development and Validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS): Protocol for an International Multistage Mixed Methods Study.

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Jul 16, 2026
First-line ibrutinib plus venetoclax for non-blastoid mantle cell lymphoma in patients ≥65 years or with TP53 mutations.

|May 22, 2026
Lymphoproliferation in inborn errors of immunity: From challenging diagnosis to histologic revision.

|May 05, 2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

|Apr 22, 2026
Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.

Pageof 28

Frequent Collaborators

15 joint publications

Alessandro Broccoli

11 joint publications

Lisa Argnani

11 joint publications

Paolo Corradini

9 joint publications

Francesca Bonifazi